相关实验视频

Updated: Jul 15, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

在预测肝细胞癌的诊断中CA 19.9和CEA的作用

Nishu Verma¹, Anjali Vinocha²

¹Department of Microbiology, Delhi State Cancer Institute, Dilshad Garden, Delhi, India.

Journal of cancer research and therapeutics

|October 3, 2023

概括

这项研究评估了CA 19-9和CEA作为肝癌诊断的生物标志物. 与CA 19-9 (64.28%) 相比,CEA的灵敏度更高 (83.67%),这表明早期发现肝细胞癌的潜力.

科学领域:

在瘤学瘤学.
生物标志物发现发现
肝细胞癌研究肝细胞癌研究

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
早期诊断和HCC的有效管理对于改善患者的治疗结果至关重要.
像CA 19-9,CEA和AFP这样的血清瘤生物标志物正在研究它们在原发性肝癌 (PHC) 中的诊断潜力.

研究的目的:

评估血清瘤标志物CA 19-9和CEA在肝细胞癌患者的诊断效用.
为了确定CA 19-9和CEA的敏感性和特异性,用于诊断肝癌.

主要方法:

来自医院数据库的68名HCC患者的回顾性横截面分析.
数据收集包括人口,病理,生化和放射性资料.
对CA 19-9和CEA的敏感性和特异性的评估.

主要成果:

在肝癌诊断中观察到CA 19-9和CEA之间存在较弱的相关性.
在肝癌诊断中,CA 19-9的灵敏度为64.28%.
对于肝癌诊断CEA的灵敏度为83.67%.

结论:

在诊断肝癌时,CEA表现出比CA 19-9更高的灵敏度.
需要进一步的研究来确定用于早期发现肝癌的新生物标志物.

关键词:

CA19-9 (癌症抗原) 是一种癌症抗原.CEA (癌胚抗原) 和AFP (阿尔法-胎蛋白) 的存在.肝细胞癌 (HCC) 是一种肝细胞癌.

更多相关视频

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

相关概念视频

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Serum Laboratory Studies, Stool Test, Breath Test

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...